uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Family Medicine and Clinical Epidemiology.
Show others and affiliations
2007 (English)In: Alimentary Pharmacology and Therapeutics, ISSN 0269-2813, E-ISSN 1365-2036, Vol. 26, no 6, 889-898 p.Article in journal (Refereed) Published
Abstract [en]


Employers pay more than just salary for their employees. Previous studies have largely focused on direct medical and prescription drug costs of gastro-oesophageal reflux disease (GERD), and few have reported on total absenteeism costs.


To examine the annual cost of illness of GERD in an employed US population by benefit category and by place of service for direct medical costs.


Retrospective data analysis from 2001 to 2004. International Classification of Diseases (ICD)-9 codes (530.1, 530.10, 530.11, 530.12, 530.19, 530.81, 787.1x, 787.2x or 251.5x) were used to identify employees with and without GERD (the control group). Measures included medical and prescription drug claims, plus indirect costs for sick leave, short- and long-term disability, and workers' compensation. For a subset of the population, the direct medical claims were analysed by place of service.


Data were available for 267,269 eligible employees of which 11,653 had gastro-oesophageal reflux disease. GERD was associated with a mean incremental cost of US $3,355 per employee of which direct medical costs accounted for 65%, prescription drug costs 17%, and indirect costs 19%. The place of service 'out-patient hospital or clinic' accounted for the largest part (47%) of the difference in medical costs.


GERD is associated with substantial direct and indirect costs, which highlight the importance of managing the disease effectively.

Place, publisher, year, edition, pages
2007. Vol. 26, no 6, 889-898 p.
Keyword [en]
Esophageal disease, Digestive diseases, America, North America, United States, Gastroesophageal reflux, Economic aspect, Public health, Health economy, Costs
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-105607DOI: 10.1111/j.1365-2036.2007.03428.xISI: 000249130100013PubMedID: 17767473OAI: oai:DiVA.org:uu-105607DiVA: diva2:221587
Available from: 2009-06-04 Created: 2009-06-04 Last updated: 2011-08-15Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Wallander, Mari-Ann
By organisation
Family Medicine and Clinical Epidemiology
In the same journal
Alimentary Pharmacology and Therapeutics
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 215 hits
ReferencesLink to record
Permanent link

Direct link